1311287-84-9

Basic information

• Product Name: N-{(2E)-3-[5-(4-amidinophenoxycarbonyl)furan-2-yl]-2-methylpropenyl}-L-glutamic acid trifluoroacetic acid salt
• Synonyms: N-{(2E)-3-[5-(4-amidinophenoxycarbonyl)furan-2-yl]-2-methylpropenyl}-L-glutamic acid trifluoroacetic acid salt
• CAS NO: 1311287-84-9
• Molecular Weight: 557.437
• Mol File: 1311287-84-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-{(2E)-3-[5-(4-amidinophenoxycarbonyl)furan-2-yl]-2-methylpropenyl}-L-glutamic acid trifluoroacetic acid salt(CAS DataBase Reference)
• NIST Chemistry Reference: N-{(2E)-3-[5-(4-amidinophenoxycarbonyl)furan-2-yl]-2-methylpropenyl}-L-glutamic acid trifluoroacetic acid salt(1311287-84-9)
• EPA Substance Registry System: N-{(2E)-3-[5-(4-amidinophenoxycarbonyl)furan-2-yl]-2-methylpropenyl}-L-glutamic acid trifluoroacetic acid salt(1311287-84-9)

Safety Data

• Hazardous Substances Data: 1311287-84-9(Hazardous Substances Data)

Upstream product

• 1311290-73-9 C₁₆H₁₃ClN₂O₄ 
• 1311287-63-4 (2E)-3-[5-(4-amidinophenoxycarbonyl)furan-2-yl]-2-methylpropenoic acid trifluoroacetic acid salt 
• 1311290-70-6 5-[(1E)-2-(tert-butoxycarbonyl)-prop-1-en-1-yl]furan-2-carboxylic acid methyl ester 
• 5904-71-2 methyl 5-formylfuran-2-carboxylate 
• 76-05-1 trifluoroacetic acid 

Relevant articles and documents

HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE

The present invention provides a hyperglycemic inhibitor having a serine protease inhibitory action, which is a novel prophylactic or therapeutic drug for diabetes. A compound represented by the following formula (I), wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof